Qualitätssicherung des thorakalen Stagings mittels [18F]FDG-PET/CT beim Adenokarzinom der Lunge: Eine retrospektive Analyse an einem Lungentumorzentrum

Authors: P M Dahlke, F F Zeuner, F Leipelt et al.
Publication: Nuklearmedizin - NuclearMedicine
Published: Apr 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

WCN26-5543 EFFICACY OF ATRASENTAN BY RENIN–ANGIOTENSIN SYSTEM INHIBITOR DOSE IN IgA NEPHROPATHY PATIENTS FROM EAST ASIA: POST HOC ANALYSIS FROM THE PHASE III ALIGN TRIAL

Hong Zhang, Jonathan Barratt et al. - Apr 2026

Read More
26-A-17267-ACC EVALUATING THE IMPACT OF HIGH SENSITIVITY TROPONIN ON HEALTHCARE UTILIZATION IN A HIGH-VOLUME QUATERNARY EMERGENCY DEPARTMENT

Lea Dahlke, Nabeel Qureshi et al. - Apr 2026

Read More
Less time Coding, more time Caring: Performance evaluation of ChatGPT-5 for ICD-10 coding of radiology reports

Tristan Ruhwedel, Julian M.M. Rogasch et al. - Apr 2026

Read More
WCN26-1861 ATRASENTAN VS PLACEBO IN SUBGROUPS OF PATIENTS FROM EAST ASIA WITH IgA NEPHROPATHY (IgAN): INTERIM DATA FROM THE PHASE III ALIGN TRIAL

Hiddo J.L. Heerspink, Meg J. Jardine et al. - Apr 2026

Read More
Qualitätssicherung des thorakalen Stagings mittels [18F]FDG-PET-CT beim Plattenepithelkarzinom der Lunge: Eine retrospektive Analyse an einem Lungentumorzentrum

P M Dahlke, F Leipelt et al. - Apr 2026

Read More